AXIM BIOTECHNOLOGIES, INC. - AXIM
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MASSMUTUAL TRUST CO FSB/ADV | History | No change | 500 | 0 | — | — | — | 0 | 0.0% | Q4 2022 | Jan 06, 2023 |